Literature DB >> 33128029

Post-transplantation cyclophosphamide restores early B-cell lymphogenesis that suppresses subsequent chronic graft-versus-host disease.

Miki Iwamoto1,2, Shuntaro Ikegawa1, Takumi Kondo1, Yusuke Meguri1, Makoto Nakamura1, Yasuhisa Sando1, Hiroyuki Sugiura1, Yuichi Sumii1, Noboru Asada1, Daisuke Ennishi1, Hisakazu Nishimori1, Keiko Fujii1, Nobuharu Fujii1, Misako Shibakura2, Yoshinobu Maeda1, Ken-Ichi Matsuoka3.   

Abstract

Entities:  

Year:  2020        PMID： 33128029     DOI： 10.1038/s41409-020-01100-0

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  Ibrutinib treatment ameliorates murine chronic graft-versus-host disease.

Authors:  Jason A Dubovsky; Ryan Flynn; Jing Du; Bonnie K Harrington; Yiming Zhong; Benjamin Kaffenberger; Carrie Yang; William H Towns; Amy Lehman; Amy J Johnson; Natarajan Muthusamy; Steven M Devine; Samantha Jaglowski; Jonathan S Serody; William J Murphy; David H Munn; Leo Luznik; Geoffrey R Hill; Henry K Wong; Kelli K P MacDonald; Ivan Maillard; John Koreth; Laurence Elias; Corey Cutler; Robert J Soiffer; Joseph H Antin; Jerome Ritz; Angela Panoskaltsis-Mortari; John C Byrd; Bruce R Blazar
Journal:  J Clin Invest       Date:  2014-10-01       Impact factor: 14.808

Review 2.  Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets.

Authors:  Robert Zeiser; Bruce R Blazar
Journal:  N Engl J Med       Date:  2017-12-28       Impact factor: 91.245

3.  Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.

Authors:  David Miklos; Corey S Cutler; Mukta Arora; Edmund K Waller; Madan Jagasia; Iskra Pusic; Mary E Flowers; Aaron C Logan; Ryotaro Nakamura; Bruce R Blazar; Yunfeng Li; Stephen Chang; Indu Lal; Jason Dubovsky; Danelle F James; Lori Styles; Samantha Jaglowski
Journal:  Blood       Date:  2017-09-18       Impact factor: 22.113

4.  Circulating T follicular helper cells with increased function during chronic graft-versus-host disease.

Authors:  Edouard Forcade; Haesook T Kim; Corey Cutler; Kathy Wang; Ana C Alho; Sarah Nikiforow; Vincent T Ho; John Koreth; Philippe Armand; Edwin P Alyea; Bruce R Blazar; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2016-03-04       Impact factor: 22.113

5.  High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Kristen E Stevenson; Haesook T Kim; Nazmim S Bhuiya; Corey S Cutler; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Clin Cancer Res       Date:  2007-10-15       Impact factor: 12.531

6.  Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans.

Authors:  Ryan Flynn; Jing Du; Rachelle G Veenstra; Dawn K Reichenbach; Angela Panoskaltsis-Mortari; Patricia A Taylor; Gordon J Freeman; Jonathan S Serody; William J Murphy; David H Munn; Stefanie Sarantopoulos; Leo Luznik; Ivan Maillard; John Koreth; Corey Cutler; Robert J Soiffer; Joseph H Antin; Jerome Ritz; Jason A Dubovsky; John C Byrd; Kelli P MacDonald; Geoff R Hill; Bruce R Blazar
Journal:  Blood       Date:  2014-05-12       Impact factor: 22.113

7.  Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence.

Authors:  Sally Arai; Bita Sahaf; Balasubramanian Narasimhan; George L Chen; Carol D Jones; Robert Lowsky; Judith A Shizuru; Laura J Johnston; Ginna G Laport; Wen-Kai Weng; Jonathan E Benjamin; Joanna Schaenman; Janice Brown; Jessica Ramirez; James L Zehnder; Robert S Negrin; David B Miklos
Journal:  Blood       Date:  2012-05-04       Impact factor: 22.113

8.  Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT.

Authors:  Angela Mensen; Korinna Jöhrens; Ioannis Anagnostopoulos; Sonya Demski; Maike Oey; Andrea Stroux; Philipp Hemmati; Jörg Westermann; Olga Blau; Friedrich Wittenbecher; Kamran Movassaghi; Martin Szyska; Sybill Thomas; Bernd Dörken; Carmen Scheibenbogen; Renate Arnold; Il-Kang Na
Journal:  Blood       Date:  2014-05-15       Impact factor: 22.113

9.  Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide.

Authors:  Christopher G Kanakry; Sudipto Ganguly; Marianna Zahurak; Javier Bolaños-Meade; Christopher Thoburn; Brandy Perkins; Ephraim J Fuchs; Richard J Jones; Allan D Hess; Leo Luznik
Journal:  Sci Transl Med       Date:  2013-11-13       Impact factor: 17.956

10.  Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Kristen E Stevenson; Haesook T Kim; Corey S Cutler; Nazmim S Bhuiya; Michael Schowalter; Vincent T Ho; Edwin P Alyea; John Koreth; Bruce R Blazar; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2009-01-23       Impact factor: 22.113
  10 in total
  3 in total

1.  Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant.

Authors:  Chenchen Zhao; Matthew Bartock; Bei Jia; Neal Shah; David F Claxton; Baldeep Wirk; Kevin L Rakszawski; Myles S Nickolich; Seema G Naik; Witold B Rybka; W Christopher C Ehmann; Raymond J Hohl; Jessica Valentin; Michelle Bernas-Peterson; Emily M Gerber; Michele Zimmerman; Joseph A Mierski; Shin Mineishi; Hong Zheng
Journal:  J Hematol Oncol       Date:  2022-05-19       Impact factor: 23.168

2.  Immune reconstitution after T-cell replete HLA haploidentical hematopoietic stem cell transplantation using high-dose post-transplant cyclophosphamide.

Authors:  Yoshinobu Maeda
Journal:  J Clin Exp Hematop       Date:  2021-02-06

Review 3.  Harnessing Treg Homeostasis to Optimize Posttransplant Immunity: Current Concepts and Future Perspectives.

Authors:  Shuntaro Ikegawa; Ken-Ichi Matsuoka
Journal:  Front Immunol       Date:  2021-08-30       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.